Pervasive Neglect of Sex Differences in Biomedical Research
- 14 October 2021
- journal article
- research article
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Perspectives in Biology
- Vol. 14 (4), a039156
- https://doi.org/10.1101/cshperspect.a039156
Abstract
Females have long been underrepresented in preclinical research and clinical drug trials. Directives by the U.S. National Institutes of Health have increased female participation in research protocols, although analysis of outcomes by sex remains infrequent. The long-held view that traits of female rats and mice are more variable than those of males is discredited, supporting equal representation of both sexes in most studies. Drug pharmacokinetic analysis reveals that, among subjects administered a standard drug dose, women are exposed to higher blood drug concentrations and longer drug elimination times. This contributes to increased adverse drug reactions in women and suggests that women are routinely overmedicated and should be administered lower drug doses than men. The past decade has seen progress in female inclusion, but key subsequent steps such as sex-based analysis and sex-specific drug dosing remain to be implemented.This publication has 52 references indexed in Scilit:
- Estradiol Acutely Suppresses Inhibition in the Hippocampus through a Sex-Specific Endocannabinoid and mGluR-Dependent MechanismNeuron, 2012
- Sex bias in neuroscience and biomedical researchNeuroscience & Biobehavioral Reviews, 2011
- Of Mice and Women: The Bias in Animal ModelsScience, 2010
- Sex Differences in Pharmacokinetics and PharmacodynamicsClinical Pharmacokinetics, 2009
- Applications of population pharmacokinetics in current drug labellingJournal of Clinical Pharmacy & Therapeutics, 2007
- The Influence of Sex on PharmacokineticsClinical Pharmacokinetics, 2003
- How Important Are Gender Differences in Pharmacokinetics?Clinical Pharmacokinetics, 2002
- Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studiesBritish Journal of Clinical Pharmacology, 1998
- Gender Effects in Pharmacokinetics and PharmacodynamicsDrugs, 1995
- Gender as a Risk Factor for Adverse Events to MedicationsDrugs, 1995